STEVEN LOUIS SHAFER, MD
Anesthesiologist Assistant at Pasteur Dr, Palo Alto, CA
License number
California 246438
Category
Osteopathic Medicine
Type
Anesthesiology
License number
California G56986
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
2
300 Pasteur Dr, Palo Alto, CA 94305
851 Indiana St UNIT 504, San Francisco, CA 94107
851 Indiana St UNIT 504, San Francisco, CA 94107
Phone
(650) 723-4000
(650) 887-2203 (Fax)
(650) 704-0558
(650) 887-2203 (Fax)
(650) 704-0558
Professional information
Dr. Steven Shafer, New York NY - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
CUMC DEPT. OF ANESTHESIOLOGY
622 W 168Th St STE 5-505, New York 10032
(212) 305-6494 (Phone)
622 W 168Th St STE 5-505, New York 10032
(212) 305-6494 (Phone)
Certifications:
Anesthesiology, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
CUMC DEPT. OF ANESTHESIOLOGY
622 W 168Th St STE 5-505, New York 10032
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
622 W 168Th St STE 5-505, New York 10032
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1983
Hospital University Penn
Graduated: 1984
Graduated: 1986
Stanford University
Graduated: 1987
Stanford University School Of Medicine
Graduated: 1983
Hospital University Penn
Graduated: 1984
Graduated: 1986
Stanford University
Graduated: 1987
Steven Louis Shafer, Stanford CA
Specialties:
Anesthesiology, General Practice
Work:
Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
Stanford University (1983)
Nicotinic-Opioid Synergy For Analgesia
US Patent:
2006025, Nov 9, 2006
Filed:
Oct 20, 2005
Appl. No.:
11/255002
Inventors:
Pamela Flood - Closter NJ, US
Steven Shafer - Palo Alto CA, US
Steven Shafer - Palo Alto CA, US
Assignee:
The Trustees of Columbia University - New York NY
International Classification:
A61K 31/485, A61K 31/4439, A61K 31/445, A61K 31/22, A61K 31/14
US Classification:
514282000, 514343000, 514546000, 514642000, 514317000
Abstract:
This invention provides two methods for reducing, or inhibiting the onset of, pain in a subject. The first method for reducing, or inhibiting the onset of, pain in a subject comprises administering to the subject (a) a nicotinic receptor agonist, and (b) an opioid receptor agonist; wherein the ratio of nicotinic receptor agonist to opioid receptor agonist administered to the subject is less than 3:4 and greater than 1:100. The second method for reducing, or inhibiting the onset of, pain in a subject comprises administering to the subject (a) a nicotinic receptor agonist at a rate of less than 3 mg per three hour period; and (b) an opioid receptor agonist at a rate of less than 4 mg per three hour period. This invention also provides two compositions, a transdermal patch, and an article of manufacture for practicing the instant methods.